Literature DB >> 11859928

Characterization of a G protein coupling "YL" motif of the human VPAC1 receptor, equivalent to the first two amino acids in the "DRY" motif of the rhodopsin family.

J W Tams1, S M Knudsen, J Fahrenkrug.   

Abstract

The conserved residues Y239 and L240 of human VPAC1 receptor are predicted to be at the same location as the asparagine and arginine in the "DRY" motif in the Rhodopsin family of G protein-coupled receptors. By comparing vasoactive intestinal peptide (VIP) binding with or without the presence of GTP-gamma-S, it was found that the deltadelta G(o) for the endogenous G-protein coupling was 1.5 kJ/mol, 0.95 kJ/mol, and 3.4 kJ/mol for theY239A, L240A, and wild-type receptor, respectively. VIP-induced cAMP production in whole cells support the results of the binding studies, as Y239A had a moderate and L240A a pronounced impaired ability to produce cAMP. The mutants had a minor influence on the intrinsic "low affinity to high affinity equilibrium," suggesting that the dominating effect of these mutants is a perturbation of the G protein-binding site. Thus, the highly diverged chemical properties of the hydrophobic "YL" motif and charged "DR(Y)" motif could be a crucial difference between the Secretin Receptor Family and the Rhodopsin Family with respect to receptor activation and G-protein coupling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11859928     DOI: 10.1385/JMN:17:3:325

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  16 in total

1.  Structure of the integral membrane domain of the GLP1 receptor.

Authors:  T M Frimurer; R P Bywater
Journal:  Proteins       Date:  1999-06-01

2.  N-Myristoylation and betagamma play roles beyond anchorage in the palmitoylation of the G protein alpha(o) subunit.

Authors:  Y Wang; R T Windh; C A Chen; D R Manning
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

3.  A disulfide bond between conserved cysteines in the extracellular loops of the human VIP receptor is required for binding and activation.

Authors:  S M Knudsen; J W Tams; B S Wulff; J Fahrenkrug
Journal:  FEBS Lett       Date:  1997-07-21       Impact factor: 4.124

4.  Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin.

Authors:  R R Franke; T P Sakmar; R M Graham; H G Khorana
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

5.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

6.  Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation.

Authors:  A Scheer; F Fanelli; T Costa; P G De Benedetti; S Cotecchia
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

Review 7.  G protein mechanisms: insights from structural analysis.

Authors:  S R Sprang
Journal:  Annu Rev Biochem       Date:  1997       Impact factor: 23.643

8.  Modulation of GDP release from transducin by the conserved Glu134-Arg135 sequence in rhodopsin.

Authors:  S Acharya; S S Karnik
Journal:  J Biol Chem       Date:  1996-10-11       Impact factor: 5.157

9.  An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor.

Authors:  S Z Zhu; S Z Wang; J Hu; E E el-Fakahany
Journal:  Mol Pharmacol       Date:  1994-03       Impact factor: 4.436

10.  The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor.

Authors:  P G Jones; C A Curtis; E C Hulme
Journal:  Eur J Pharmacol       Date:  1995-02-15       Impact factor: 4.432

View more
  7 in total

1.  Differential determinants for coupling of distinct G proteins with the class B secretin receptor.

Authors:  Gene L Garcia; Maoqing Dong; Laurence J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

Review 2.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 3.  Conformational switches in the VPAC(1) receptor.

Authors:  Ingrid Langer
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Similarity between class A and class B G-protein-coupled receptors exemplified through calcitonin gene-related peptide receptor modelling and mutagenesis studies.

Authors:  Shabana Vohra; Bruck Taddese; Alex C Conner; David R Poyner; Debbie L Hay; James Barwell; Philip J Reeves; Graham J G Upton; Christopher A Reynolds
Journal:  J R Soc Interface       Date:  2012-12-12       Impact factor: 4.118

5.  Mechanisms involved in VPAC receptors activation and regulation: lessons from pharmacological and mutagenesis studies.

Authors:  Ingrid Langer
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-30       Impact factor: 5.555

6.  Agnathan VIP, PACAP and their receptors: ancestral origins of today's highly diversified forms.

Authors:  Stephanie Y L Ng; Billy K C Chow; Jun Kasamatsu; Masanori Kasahara; Leo T O Lee
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

7.  Key interactions by conserved polar amino acids located at the transmembrane helical boundaries in Class B GPCRs modulate activation, effector specificity and biased signalling in the glucagon-like peptide-1 receptor.

Authors:  Denise Wootten; Christopher A Reynolds; Kevin J Smith; Juan C Mobarec; Sebastian G B Furness; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton
Journal:  Biochem Pharmacol       Date:  2016-08-26       Impact factor: 5.858

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.